Keros Therapeutics Non-Current Deferred Liabilities (Quarterly) Insights

Keros Therapeutics, Inc. (KROS)

19.50 +0.62 (+3.28%) USD | NASDAQ | Jan 13, 16:00

18.50 -1.00 (-5.13%) Pre-Market: 08:20

View Non-Current Deferred Liabilities (Quarterly) for KROS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Non-Current Deferred Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Non-Current Deferred Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Non-Current Deferred Liabilities (Quarterly) Benchmarks

Start Trial